Aktis Oncology, a clinical stage biotechnology company discovering and developing novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, announced the...
Tempus, a leader in artificial intelligence and precision medicine, announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with...
Nanite, Inc. and SalioGen Therapeutics announced a research collaboration that will utilize Nanite's SAYER™ delivery platform to develop a lung-targeting polymer nanoparticle (PNP) designed to integrate...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Anocca AB (Anocca), a leading T-cell receptor-engineered T-cell (TCR-T) therapeutics company, and Shinobi Therapeutics (Shinobi), developer of immune-evasive induced pluripotent stem cell (iPSC)-derived CD8...
